Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)

Title: Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)
Authors: Lampis A; Ratti M; Ghidini M; Mirchev MB; Okuducu AF; Valeri N; Hahne JC
Contributors: Lampis, A; Ratti, M; Ghidini, M; Mirchev, Mb; Okuducu, Af; Valeri, N; Hahne, Jc
Publication Year: 2021
Collection: IRInSubria - Institutional Repository Insubria (Università degli Studi dell’Insubria)
Subject Terms: Adoptive T-cell therapy; Immune checkpoint inhibitor; Immunotherapy; Oesophageal cancer; Oncolytic viruse; Peptide vaccine
Description: Oesophageal cancer is one of the most aggressive malignancies with limited treatment options, thus resulting in a high morbidity and mortality. With 5-year survival rates of only 5-10%, oesophageal cancer holds a dismal prognosis for patients. In order to improve overall survival, the early diagnosis and tools for patient stratification for personalized treatment are urgent needs. A minority of oesophageal cancers belong to the spectrum of Lynch syndrome-associated cancers and are characterized by microsatellite instability (MSI). Microsatellite instability is a consequence of defective mismatch repair protein functions and it has been well characterized in other gastrointestinal tumours, such as colorectal and gastric cancer. In the latter, high levels of MSI are associated with a better prognosis and with an increased benefit to immune-based therapies. Therefore, similar therapeutic approaches could offer an opportunity of treatment for oesophageal cancer patients with MSI. Apart from immune checkpoint inhibitors, other immunotherapies such as adoptive T-cell transfer, peptide vaccine and oncolytic viruses are under investigation in oesophageal cancer patients. In the present review, the rationale and current knowledge about immunotherapies in oesophageal cancer are summarised.
Document Type: article in journal/newspaper
File Description: ELETTRONICO
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/33846775; info:eu-repo/semantics/altIdentifier/wos/WOS:000639474100001; volume:47; issue:6; firstpage:1; lastpage:12; numberofpages:12; journal:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; https://hdl.handle.net/11383/2200615
DOI: 10.3892/ijmm.2021.4930
Availability: https://hdl.handle.net/11383/2200615; https://doi.org/10.3892/ijmm.2021.4930
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.2D9F9EBF
Database: BASE